Our previous study demonstrated that Shh signaling molecules expressed in human chronic myeloid leukemia (CML) cells may regulate Bcr-Abl activation [13]. This evidence concerns the gene SHH and chronic myelogenous leukemia, BCR-ABL1 positive.